OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
October 12, 2021
Evaluating patient data in the context of complementary information can provide comprehensive market insights for product strategy.
Agile methodologies provide an alternative to hierarchical, siloed and sequential way of managing activities and have the potential to dramatically reduce set-up time for new business or digital capabilities.
September 13, 2021
Landmark Bio CEO Ran Zheng talks about the value of collaborating with best-in-class partners.
Mark Davies and Paul Riley outline their blueprint for exploring how healthcare companies can leverage real-world evidence to access and engage customers more effectively.
August 30, 2021
Using the interview process to ensure high organizational standards.
August 11, 2021
With opportunity and risk lurking in equal measure, today’s key considerations for biopharma startups when building their leadership teams and product go-to-market strategies are outlined.
July 26, 2021
Biopharma deal-making is on the rise again and now is the time for biopharma companies to embrace M&As to prepare for future growth.
June 22, 2021
Pharma should be the ‘glue’ that bonds healthcare organizations together to solve society’s most pressing challenges.
May 19, 2021
Amgen board member and serial CEO Fred Hassan talks about the three levers Fortune 500 C-suites should consider as they position their firms from pilots to enterprise-wide digital transformation.
April 14, 2021
The “blank-check” method has emerged as a worthwhile bet for biopharma companies looking to raise capital and go public, but will its attractiveness fade along with the pandemic?